Document is current
Any future updates will be listed below
-
Authors
Baumert, Philipp https://orcid.org/0000-0002-5463-1954
Scharbert, Julia https://orcid.org/0009-0003-1998-7941
Strutzenberger, Gerda https://orcid.org/0000-0001-5218-6183
Boehmer, Michael https://orcid.org/0009-0004-9025-6516
AminiAghdam, Soran https://orcid.org/0000-0001-9310-6768
Woergoetter, Simon https://orcid.org/0009-0008-5972-4085
Fink, Christian https://orcid.org/0000-0002-8446-2434
-
Funding
Funding for this research was provided by:
UMIT TIROL-Private Universität für Gesundheitswissenschaften und -technologie GmbH
- License Information
-
More Information
Article History
Received: 14 October 2025
Accepted: 5 February 2026
First Online: 3 March 2026
Declarations
:
: C. Fink—Karl Storz: IP royalties; Medacta: IP royalties, paid consultant, fellowship support; Stryker: paid consultant; S&N: paid consultant; Arthrex: fellowship support. P. Baumert, J. Scharbert, G. Strutzenberger, M. Boehmer, S. AminiAghdam and S. Woergoetter declare that they have no competing interests.
: This study protocol describes research involving human participants. Ethical approval was obtained from Ethics Committee of the Medical University of Innsbruck (EK-Nr: 1379/2023]. All procedures will be conducted in accordance with the Declaration of Helsinki.
: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
